Profusa (PFSA) Capital Expenditures (2024 - 2026)
Profusa's (PFSA) quarterly Capital Expenditures came in at $50000.0 in Q1 2026, up 5100.0% year-on-year from $961.54 in Q1 2025, and up 196.15% quarter-over-quarter from -$52000.0 in Q4 2025.
Profusa (PFSA) Capital Expenditures (2024 - 2026) Analysis & Trends
Profusa's Capital Expenditures history runs 3 years deep, the most recent figure standing at $50000.0 for Q1 2026.
- On a quarterly basis, Capital Expenditures rose 5100.0% year-over-year to $50000.0 in Q1 2026; TTM through Mar 2026 was -$324000.0, a N/A change from a year earlier, with the FY2025 full-year figure at -$53000.0, down 312.0% from the prior year.
- Capital Expenditures grew to $50000.0 in Q1 2026 per PFSA's latest filing, from -$52000.0 in the prior quarter.
- Across five years, Capital Expenditures topped out at $50000.0 in Q1 2026 and bottomed at -$321000.0 in Q4 2024.
- The 3-year median for Capital Expenditures is -$26500.0 (2025), against an average of -$81000.0.
- Across the five-year window, Capital Expenditures jumped 83.8% in 2025 and soared 5100.0% in 2026, its largest moves.
- Year by year, Capital Expenditures stood at -$321000.0 in 2024, then soared by 83.8% to -$52000.0 in 2025, then soared by 196.15% to $50000.0 in 2026.
- Per Business Quant, the three latest PFSA Capital Expenditures figures stand at $50000.0 (Q1 2026), -$52000.0 (Q4 2025), and -$1000.0 (Q1 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capital Expenditures (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 399.00 Mn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 166.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 488.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 177.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 64.90 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 76.60 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | -85.46 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 178.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Profusa | 23,566.40 | -351,433.60 | - | 50,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 50,000.00 |
| Mar 31, 2026 | 50,000.00 |
| Dec 31, 2025 | -52,000.00 |
| Dec 31, 2025 | -52,000.00 |
| Mar 31, 2025 | -1,000.00 |
| Mar 31, 2025 | -1,000.00 |
| Dec 31, 2024 | -321,000.00 |
| Dec 31, 2024 | -321,000.00 |